[1] Reichlin T,Hochholzer W,Stelzig C,et al. Incremental value of copeptin for rapid rule out of acute myocardial infarction[J]. J Am Coll Cardiol,2009,54(1):60-68.[2] Stoiser B,Mrtl D,Hülsmann M,et al. Copeptin, a fragment of the vasopressin precursor, as a novel predictor of outcome in heart failure[J]. Eur J Clin Invest,2006,36(11):771-778.[3] Neuhold S,Huelsmann M,Strunk G,et al. Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease[J]. J Am Coll Cardiol,2008,52(4):266-272.[4] 顾东风,黄广勇,何 江,等.中国心力衰竭流行病学调查及患病率[J].中华心血管病杂志,2003,31(1):3-6.[5] Dickstein K, Cohen-Solal A, Filippatos G, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)[J]. Eur J Heart Fail,2008,10(10):933-989.[6] 王玉亭,王庭槐.扩张型心肌病发病机理及治疗进展[J].中国心血管杂志,2005,10(3):230-232.[7] Tousoulis D, Kampoli AM, Stefanadi E, et al. New biochemical markers in acute coronary syndromes[J].Curr Med Chem,2008,15(13):1288-1296.[8] Maisel AS, Krishnaswamy P, Nowak RM,et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure[J]. N Engl J Med,2002,347(3):161-167.[9] Voors AA, von Haehling S, Anker SD,et al. C-terminal provasopressin(copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction:results from the OPTIMAAL study[J].Eur Heart J,2009,30(10):1187-1194.[10] Khan SQ, Dhillon OS, O′Brien RJ, et al. C-terminal provasopressin(copeptin) is a novel and prognostic marker in acute myocardial infarction:Leicester Acute Myocardial Infarction Peptide(LAMP)study[J]. Circulation,2007,115(16):2103-2110.[11] Kelly D, Squire IB, Khan SQ, et al. C-terminal pro-vasopressin(copeptin) is associated with left ventricular dysfunction,remodeling, and clinical heart failure in survivors of myocardial infarction[J]. J Card Fail,2008,14(9):739-745. |